About ATP
ATP is a venture capital firm founded in 2014. It is primarily based out of New York City, United States. As of Apr 2026, ATP has invested in 11 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from High Tech to Enterprise Applications and Life Sciences. Most recently it participated in the $***** Seed round of Deteqt Overall, ATP portfolio has seen 1 IPO and 5 acquisitions including key companies like Northvolt, AEye and SubjectWell. A lot of funds co-invest with ATP, with names like OMERS sharing a substantial percentage of its portfolio. ATP has team of 6 people including 2 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 2 more
Portfolio IPOs
Portfolio Acquisitions
ATP's List of Top Investments
ATP has a portfolio of 11 companies. Their most notable investmentis in Alafair BiosciencesTheir portfolio spans across United States, Australia and Sweden. They have invested in High Tech, Enterprise Applications, Life Sciences and 10 other sectors, across stages such as Seed, Series A and 2 more. Here is the list of top investments by ATP:1. Northvolt
Manufacturer of lithium-ion batteries for electric vehicles. It provides solutions for new production technologies to deliver low-cost lithium-ion batteries to be used in electric and off-highway vehicles. It provides custom cells optimized for a particular application, battery system, and more.
Key facts about Northvolt
- Location: Sweden
- Annual Revenue: $100M - $500M as on Dec 31, 2022
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $9B
- Employee Count: 1,663 as on May 31, 2026
- Investors: GIC, Bundesministerium fur Wirtschaft und Klimaschutz and 51 Others
- Latest Funding Round: Conventional Debt, Mar 14, 2024, $*****
- Highlight: Acquired

2. AEye
Platform offering artificial intelligence and cloud enabled solutions. It provides sensor solutions for automobiles. It offers hardware products that are solid-state lidars with ADAS functionality. It also offers AI-enabled software for perception with features like real-time integration of pixels, and predictive solutions.
Key facts about AEye
- Founded Year: 2013
- Location: Pleasanton (United States)
- Annual Revenue: $0 - $1M as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $71.4M
- Employee Count: 88 as on May 31, 2026
- Investors: Pegasus Tech Ventures, ATP and 21 Others
- Latest Funding Round: Conventional Debt, Sep 01, 2021, $*****
- Highlight: Public
3. SubjectWell
Provider of clinical trials marketplace offering solutions for patient recruitment. It offers a technology platform that identifies patients who are interested and gives them an easy introduction to clinical trials. It alerts interested candidates to clinical trials and also offer quality referrals through prescreening.
Key facts about SubjectWell
- Founded Year: 2012
- Location: Austin (United States)
- Stage: Acquired
- Total Funding till date: $46.8M
- Employee Count: 160 as on May 31, 2026
- Investors: ATP, Healthy Ventures and 10 Others
- Latest Funding Round: Series B, Oct 20, 2022, $*****
- Highlight: Acquired

4. Seismos
Provider of subsurface intelligence and analytics for oil and gas sectors. It offers acoustic sensing technology for real-time monitoring and optimization of operations. The company's technology supports intelligent completions, pipeline integrity, and geothermal stimulation. It delivers data for optimizing stage design, fluid placement, and perforation strategy. The company provides solutions for supervised and unsupervised closed-loop fracturing.
Key facts about Seismos
- Founded Year: 2013
- Location: Austin (United States)
- Stage: Series C
- Total Funding till date: $29.5M
- Employee Count: 76 as on May 31, 2026
- Investors: ATP, Javelin Venture Partners and 6 Others
- Latest Funding Round: Series C, Jul 10, 2024, $*****
- Highlight: Editors' Pick
Biomaterials and biomedical devices that enhance internal wound healing. It develops cross-linked polysaccharide hydrogel films to address the post-surgical complication of unwanted soft tissue attachments or tethering between opposing tissue surfaces.
Key facts about Alafair Biosciences
- Founded Year: 2011
- Location: Austin (United States)
- Stage: Series B
- Total Funding till date: $13.7M
- Employee Count: 61 as on May 31, 2026
- Investors: ATP, UT System and 4 Others
- Latest Funding Round: Series B, Apr 18, 2019, $*****
- Highlight: Editors' Pick
ATP's Year-on-Year Investment Trends
ATP has invested in 11 companies over the last 10 years, with an average of 0 new investment annually in the last 10 years. In 2025, it made 1 investment, while as of Apr 2026, it has made 1 investment in this year. Its most recent first time investment was in Deteqt and most recent follow-on round was in Deteqt.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 1 | 1 |
2025 | 1 | 0 | 1 |
2024 | 0 | 0 | 0 |
2023 | 0 | 0 | 0 |
2022 | 0 | 0 | 0 |
2021 | 1 | 0 | 1 |
2020 | 0 | 0 | 0 |
2019 | 0 | 0 | 0 |
2018 | 1 | 0 | 1 |
ATP's Investments by Stage
ATP has made 1 investment in Seed stage with an average round size of $471K, 1 investment in Series A stage with an average round size of $2M, 1 investment in Series B stage with an average round size of $10.5M and 1 investment in Series C stage with an average round size of $2.75B.Stage of entry | No. of Investments |
|---|---|
Seed | 1 |
Series A | 1 |
Series B | 1 |
Series C | 1 |
Note: We have considered here, only first round of investments
ATP's Investments by Sector
ATP has a diverse portfolio, with companies operating in the High Tech, Energy Tech, Environment Tech, Internet of Things - Industry Applications and Life Sciences. Notably, it has invested in 9 Tech companies, 8 Enterprise (B2B) companies, 6 Software companies and at least 4 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
High Tech | 3 |
Energy Tech | 2 |
Environment Tech | 1 |
Internet of Things - Industry Applications | 1 |
Life Sciences | 1 |
Others | 1 |
Note: We have considered here, only first round of investments
ATP's Investments by Geography
ATP has made most investments in United States (2), followed by Australia where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 2 |
Australia | 1 |
Sweden | 1 |
Note: We have considered here, only first round of investments
ATP's recent investments
ATP has made 1 investments in 2026 so far - Deteqt.Here are the most recent investments by ATP:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Apr 14, 2026 | Australia | Seed | 8665 | [+4] | |
Mar 25, 2025 | Australia | Seed | 3516 | ||
Jun 09, 2021 | Sweden | Series C | 6526 | [+11] | |
Dec 08, 2018 | United States | Series B | 9053 | ||
Aug 09, 2016 | United States | Series A | 6023 |
IPOs and Publicly Listed companies in ATP's Portfolio
1 of ATP's portfolio company became public - AEye. It got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Aug 2021.Here are ATP's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Aug 18, 2021 | - | - | 3457 |
Acquired companies in ATP's Portfolio
5 companies from ATP's portfolio have been acquired. The most recent acquisition was Northvolt in Apr 2025 by Scania for $*****.Here are ATP's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 11, 2025 | Jun 09, 2021 | Series C | 8204 | |
Apr 30, 2024 | - | - | 5982 | |
Jan 10, 2020 | - | - | 5068 | |
Jun 19, 2019 | - | - | 8633 | |
Feb 29, 2016 | - | - | 8851 |
Team profile of ATP
ATP has a team of 6 members including 2 Partners and 4 Venture Partners located in United States and United Kingdom. ATP's team does not sit on the board of any company as of now.Here is a list of all team members in ATP:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Austin | - | ||
Partner | Houston | - | ||
Venture Partner | Austin | - | ||
Venture Partner | Kensington | - | - | |
Venture Partner | San Francisco | - | ||
Venture Partner | Austin | - |
Co-investors of ATP
Over the past 10 years, 59 investors have co-invested in ATP's portfolio companies. This includes funds and angels.
- Invested before ATP: Vattenfall, Vinnova and 26 others have invested in rounds before ATP. There is 1 company where Vattenfall has invested before ATP and 1 company where Vinnova has invested before ATP.
- Top Co-investors of ATP: 11 investors entered a company along with ATP. These include investors like OMERS (1 company).
- Invested after ATP: A total of 20 investors have invested in ATP's portfolio after their investments. Top Investors include Ava (1 company), AMF (1 company) and PCS Holding (1 company).
Recent News related to ATP
•
Deteqt nabs $5M to scale quantum diamond chips for defence and mineral sensingStartup Daily•Apr 14, 2026•Deteqt, ATP, Main Sequence, BOKA Group
•
MedTrace raises $19M for its PET-boosting technologyMassDevice•Sep 21, 2023•MedTrace, MedTrace, ATP, Swisscanto and 1 other
•
Ascidian Therapeutics Rises From Atp’s Ocean Floor With $50m And Dyne’s Former CeoFierce Biotech•Oct 12, 2022•Ascidian Therapeutics, ATP
•
Northvolt raises $1.1 billion to support factory rollout plans in EuropeWebwire•Jul 07, 2022•Northvolt, Ava, Baillie Gifford, Folksam and 25 others
•
Biotech startup Marengo unveils $80M and a new way to get T cells to fight cancerMedCity News•Nov 08, 2021•Marengo, Apple Tree Partners, ATP
•
•
Alafair Biosciences Secures $2.0 Million Series A Financing RoundBusiness Wire•Aug 09, 2016•Alafair Biosciences, ATP, Innovation UT System
